Literature DB >> 19448552

High resolution ultra high field magnetic resonance imaging of glioma microvascularity and hypoxia using ultra-small particles of iron oxide.

Gregory A Christoforidis1, Ming Yang, Marinos S Kontzialis, Douglas G Larson, Amir Abduljalil, Michelle Basso, Weilian Yang, Abhik Ray-Chaudhury, Johannes Heverhagen, Michael V Knopp, Rolf F Barth.   

Abstract

OBJECTIVES: This study assessed whether ultra-small particles of iron oxide (USPIO) intravascular contrast agent could enhance visualization of tumor microvascularity in F98 glioma bearing rats by means of ultra high field (UHF) high-resolution gradient echo (GRE) magnetic resonance imaging (MRI). In an effort to explain differences in visualization of microvascularity before and after USPIO administration, hypoxia and vessel diameters were assessed on corresponding histopathologic sections.
MATERIALS AND METHODS: F98 glioma cells were implanted stereotactically into the brains of syngeneic Fischer rats. Based on clinical criteria, rats were imaged 1 to 2 days before their death with and without USPIO contrast on an 8 Tesla MRI. To identify hypoxic regions of the brain tumor by immunohistochemical staining, a subset of animals also received a nitroimidazole-based hypoxia marker, EF5, before euthanasia. These sections then were compared with noncontrast enhanced MR images. The relative caliber of tumor microvasculature, compared with that of normal brain, was analyzed in a third group of animals.
RESULTS: After USPIO administration, UHF high-resolution GRE MRI consistently predicted increased microvascular density relative to normal gray matter when correlated with histopathology. The in-plane visibility of glioma microvascularity in 22 rats increased by an average of 115% and signal intensity within the tumor decreased by 13% relative to normal brain. Tumor microvascularity identified on noncontrast MR images matched hypoxic regions identified by immunohistochemical staining with a sensitivity of 83% and specificity of 89%. UHF GRE MRI was able to resolve microvessels less than 20 micro in diameter, although differences in tumor vessel size did not consistently account for differences in visualization of microvascularity.
CONCLUSIONS: USPIO administration significantly enhanced visualization of tumor microvascularity on gradient echo 8 T MRI and significantly improved visualization of tumor microvascularity. Microvascularity identified on precontrast images is suspected to be partly associated with hypoxia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19448552      PMCID: PMC2830862          DOI: 10.1097/RLI.0b013e3181a8afea

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  69 in total

1.  Rapid simultaneous mapping of T2 and T2* by multiple acquisition of spin and gradient echoes using interleaved echo planar imaging (MASAGE-IEPI).

Authors:  David L Thomas; Mark F Lythgoe; David G Gadian; Roger J Ordidge
Journal:  Neuroimage       Date:  2002-04       Impact factor: 6.556

2.  Visualization of microvascularity in glioblastoma multiforme with 8-T high-spatial-resolution MR imaging.

Authors:  Gregory A Christoforidis; John C Grecula; Herbert B Newton; Allahyar Kangarlu; Amir M Abduljalil; Petra Schmalbrock; Donald W Chakeres
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

3.  Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study.

Authors:  Stephan G Wetzel; Soonmee Cha; Glyn Johnson; Peter Lee; Meng Law; David L Kasow; Sean D Pierce; Xiaonan Xue
Journal:  Radiology       Date:  2002-09       Impact factor: 11.105

4.  New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.

Authors:  M Taupitz; J Schnorr; C Abramjuk; S Wagner; H Pilgrimm; H Hünigen; B Hamm
Journal:  J Magn Reson Imaging       Date:  2000-12       Impact factor: 4.813

5.  Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging.

Authors:  C Weltens; J Menten; M Feron; E Bellon; P Demaerel; F Maes; W Van den Bogaert; E van der Schueren
Journal:  Radiother Oncol       Date:  2001-07       Impact factor: 6.280

Review 6.  Magnetic resonance imaging for in vivo assessment of tissue oxygen concentration.

Authors:  M C Krishna; S Subramanian; P Kuppusamy; J B Mitchell
Journal:  Semin Radiat Oncol       Date:  2001-01       Impact factor: 5.934

7.  Intratumour heterogeneity in microvessel oxyhaemoglobin saturations.

Authors:  K Måseide; E K Rofstad
Journal:  Cancer Lett       Date:  2001-01-26       Impact factor: 8.679

Review 8.  Magnetic resonance imaging applications in the evaluation of tumor angiogenesis.

Authors:  M Neeman; J M Provenzale; M W Dewhirst
Journal:  Semin Radiat Oncol       Date:  2001-01       Impact factor: 5.934

9.  Detection of deoxygenation-related signal change in acute ischemic stroke patients by T2*-weighted magnetic resonance imaging.

Authors:  Hajime Tamura; Jun Hatazawa; Hideto Toyoshima; Eku Shimosegawa; Toshio Okudera
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

Review 10.  Molecular imaging of tumor angiogenesis.

Authors:  Nick G Costouros; Felix E Diehn; Steven K Libutti
Journal:  J Cell Biochem Suppl       Date:  2002
View more
  8 in total

1.  MRI using ferumoxytol improves the visualization of central nervous system vascular malformations.

Authors:  Edit Dósa; Suchita Tuladhar; Leslie L Muldoon; Bronwyn E Hamilton; William D Rooney; Edward A Neuwelt
Journal:  Stroke       Date:  2011-04-14       Impact factor: 7.914

2.  "Tumoral pseudoblush" identified within gliomas at high-spatial-resolution ultrahigh-field-strength gradient-echo MR imaging corresponds to microvascularity at stereotactic biopsy.

Authors:  Gregory A Christoforidis; Ming Yang; Amir Abduljalil; Abhik R Chaudhury; Herbert B Newton; John M McGregor; Clara R Epstein; William T C Yuh; Sydeaka Watson; Pierre-Marie L Robitaille
Journal:  Radiology       Date:  2012-05-24       Impact factor: 11.105

3.  A combined diffusion tensor imaging and Ki-67 labeling index study for evaluating the extent of tumor infiltration using the F98 rat glioma model.

Authors:  Kai Wang; Tingting Ha; Xuzhu Chen; Shaowu Li; Lin Ai; Jun Ma; Jianping Dai
Journal:  J Neurooncol       Date:  2018-01-02       Impact factor: 4.130

4.  Maintaining brain health by monitoring inflammatory processes: a mechanism to promote successful aging.

Authors:  Caterina Rosano; Anna L Marsland; Peter J Gianaros
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

5.  Post-embolisation susceptibility changes in giant meningiomas: multiparametric histogram analysis using non-contrast-enhanced susceptibility-weighted PRESTO, diffusion-weighted and perfusion-weighted imaging.

Authors:  Tomokazu Nishiguchi; Takeshi Iwakiri; Kohji Hayasaki; Masahiko Ohsawa; Tetuya Yoneda; Yutaka Mitsuhashi; Akimasa Nishio; Vincent Dousset; Yukio Miki
Journal:  Eur Radiol       Date:  2012-09-26       Impact factor: 5.315

6.  Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration.

Authors:  Eunna Chung; Laura M Ricles; Ryan S Stowers; Seung Yun Nam; Stanislav Y Emelianov; Laura J Suggs
Journal:  Nano Today       Date:  2012-11-17       Impact factor: 20.722

Review 7.  The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II).

Authors:  Tanvi Vaidya; Archi Agrawal; Shivani Mahajan; M H Thakur; Abhishek Mahajan
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

8.  Intratumor mapping of intracellular water lifetime: metabolic images of breast cancer?

Authors:  Charles S Springer; Xin Li; Luminita A Tudorica; Karen Y Oh; Nicole Roy; Stephen Y-C Chui; Arpana M Naik; Megan L Holtorf; Aneela Afzal; William D Rooney; Wei Huang
Journal:  NMR Biomed       Date:  2014-05-05       Impact factor: 4.044

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.